![](/img/cover-not-exists.png)
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31
Gelmon, K. A., Boyle, F. M., Kaufman, B., Huntsman, D. G., Manikhas, A., Di Leo, A., Martin, M., Schwartzberg, L. S., Lemieux, J., Aparicio, S., Shepherd, L. E., Dent, S., Ellard, S. L., Tonkin, K., PVolume:
33
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2014.56.9590
Date:
May, 2015
File:
PDF, 368 KB
english, 2015